GILD |
Gilead Sciences, Inc. |
137.03B |
8.56% |
|
|
|
|
|
109.95 |
-0.07% |
25.23% |
31.39% |
---|
AMGN |
Amgen Inc. |
162.78B |
7.90% |
|
|
|
|
|
303.01 |
1.71% |
21.37% |
8.26% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
75.29B |
7.53% |
|
|
|
|
|
700.33 |
0.62% |
36.18% |
59.68% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
124.35B |
7.35% |
|
|
|
|
|
484.24 |
0.81% |
29.71% |
30.05% |
---|
IQV |
IQVIA Holdings Inc. |
33.64B |
3.60% |
|
|
|
|
|
191.04 |
-1.53% |
36.68% |
50.90% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
32.44B |
3.06% |
|
|
|
|
|
250.59 |
-0.16% |
41.52% |
33.50% |
---|
ARGX |
argenx SE |
39.16B |
2.94% |
|
|
|
|
|
644.48 |
-0.46% |
31.77% |
42.46% |
---|
MTD |
Mettler-Toledo International Inc. |
26.91B |
2.57% |
|
|
|
|
|
1,286.54 |
-1.27% |
33.35% |
46.61% |
---|
WAT |
Waters Corporation |
22.26B |
2.23% |
|
|
|
|
|
374.82 |
-1.57% |
34.93% |
32.26% |
---|
BIIB |
Biogen Inc. |
20.59B |
2.20% |
|
|
|
|
|
140.64 |
2.59% |
37.81% |
56.88% |
---|
BNTX |
BioNTech SE |
28.77B |
2.13% |
|
|
|
|
|
120.01 |
1.81% |
45.15% |
110.10% |
---|
ILMN |
Illumina, Inc. |
14.92B |
2.13% |
|
|
|
|
|
94.20 |
-3.09% |
46.36% |
37.89% |
---|
NTRA |
Natera, Inc. |
21.43B |
1.99% |
|
|
|
|
|
162.31 |
-3.50% |
53.42% |
52.65% |
---|
UTHR |
United Therapeutics Corporation |
16.12B |
1.59% |
|
|
|
|
|
361.10 |
-1.70% |
35.09% |
97.66% |
---|
BGNE |
BeiGene, Ltd. |
20.21B |
1.41% |
|
|
|
|
|
184.71 |
0.49% |
39.65% |
32.18% |
---|
MRNA |
Moderna, Inc. |
13.67B |
1.37% |
|
|
|
|
|
35.53 |
5.34% |
87.43% |
82.80% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.03B |
1.37% |
|
|
|
|
|
120.69 |
3.94% |
34.71% |
22.61% |
---|
INCY |
Incyte Corporation |
13.96B |
1.31% |
|
|
|
|
|
72.11 |
1.02% |
42.37% |
83.22% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
13.01B |
1.25% |
|
|
|
|
|
68.25 |
-0.70% |
33.04% |
28.31% |
---|
INSM |
Insmed Incorporated |
14.50B |
1.22% |
|
|
|
|
|
81.06 |
-3.05% |
46.27% |
4.03% |
---|
TECH |
Bio-Techne Corporation |
10.26B |
1.15% |
|
|
|
|
|
64.92 |
-0.87% |
40.49% |
40.03% |
---|
GMAB |
Genmab A/S |
14.19B |
1.10% |
|
|
|
|
|
22.34 |
-0.45% |
74.56% |
62.70% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
10.15B |
1.09% |
|
|
|
|
|
106.28 |
-1.96% |
49.27% |
16.33% |
---|
PCVX |
Vaxcyte, Inc. |
9.94B |
1.00% |
|
|
|
|
|
79.74 |
-3.31% |
62.20% |
46.37% |
---|
EXEL |
Exelixis, Inc. |
10.31B |
0.95% |
|
|
|
|
|
36.85 |
5.02% |
35.76% |
27.34% |
---|
CRL |
Charles River Laboratories International... |
8.34B |
0.94% |
|
|
|
|
|
163.02 |
0.47% |
44.67% |
44.83% |
---|
MEDP |
Medpace Holdings, Inc. |
10.37B |
0.86% |
|
|
|
|
|
340.22 |
-1.34% |
56.20% |
27.67% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
13.67B |
0.84% |
|
|
|
|
|
128.60 |
0.05% |
11.93% |
15.81% |
---|
RGEN |
Repligen Corporation |
8.91B |
0.76% |
|
|
|
|
|
158.99 |
-2.26% |
50.01% |
31.25% |
---|
ASND |
Ascendis Pharma A/S |
9.12B |
0.65% |
|
|
|
|
|
152.43 |
-1.39% |
44.73% |
11.07% |
---|
RVMD |
Revolution Medicines, Inc. |
7.54B |
0.62% |
|
|
|
|
|
41.33 |
-2.20% |
66.81% |
26.62% |
---|
HALO |
Halozyme Therapeutics, Inc. |
7.11B |
0.61% |
|
|
|
|
|
57.75 |
0.54% |
37.56% |
45.45% |
---|
BRKR |
Bruker Corporation |
7.70B |
0.61% |
|
|
|
|
|
50.82 |
-3.97% |
46.26% |
60.00% |
---|
MDGL |
Madrigal Pharmaceuticals, Inc. |
7.33B |
0.58% |
|
|
|
|
|
336.23 |
-4.22% |
61.15% |
24.27% |
---|
BPMC |
Blueprint Medicines Corporation |
5.90B |
0.54% |
|
|
|
|
|
92.25 |
-2.23% |
66.68% |
15.72% |
---|
CYTK |
Cytokinetics, Incorporated |
5.93B |
0.54% |
|
|
|
|
|
50.26 |
-1.68% |
54.27% |
66.40% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
5.10B |
0.51% |
|
|
|
|
|
32.32 |
-1.13% |
57.02% |
68.51% |
---|
LEGN |
Legend Biotech Corporation |
7.28B |
0.48% |
|
|
|
|
|
39.70 |
2.00% |
65.05% |
20.22% |
---|
ALKS |
Alkermes plc |
5.74B |
0.46% |
|
|
|
|
|
35.32 |
-0.51% |
55.46% |
54.71% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
3.47B |
0.45% |
|
|
|
|
|
37.46 |
1.63% |
70.01% |
42.91% |
---|
ROIV |
Roivant Sciences Ltd. |
7.62B |
0.44% |
|
|
|
|
|
10.68 |
-0.37% |
32.36% |
68.47% |
---|
BBIO |
BridgeBio Pharma, Inc. |
6.96B |
0.41% |
|
|
|
|
|
36.85 |
0.12% |
60.00% |
23.25% |
---|
ADMA |
ADMA Biologics, Inc. |
3.74B |
0.41% |
|
|
|
|
|
15.84 |
-1.49% |
61.47% |
19.44% |
---|
KRYS |
Krystal Biotech, Inc. |
5.40B |
0.39% |
|
|
|
|
|
187.86 |
2.87% |
46.99% |
31.69% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
3.94B |
0.36% |
|
|
|
|
|
42.59 |
-4.25% |
71.90% |
25.52% |
---|
PTCT |
PTC Therapeutics, Inc. |
3.91B |
0.35% |
|
|
|
|
|
50.69 |
0.62% |
48.14% |
18.88% |
---|
AXSM |
Axsome Therapeutics, Inc. |
6.72B |
0.34% |
|
|
|
|
|
137.75 |
6.70% |
49.12% |
14.02% |
---|
APLS |
Apellis Pharmaceuticals, Inc. |
3.42B |
0.33% |
|
|
|
|
|
27.52 |
-2.93% |
43.44% |
38.54% |
---|
NUVL |
Nuvalent, Inc. |
5.65B |
0.33% |
|
|
|
|
|
79.49 |
-3.52% |
47.10% |
36.59% |
---|
ACLX |
Arcellx, Inc. |
3.45B |
0.32% |
|
|
|
|
|
63.75 |
-2.83% |
46.12% |
25.56% |
---|
BHVN |
Biohaven Pharmaceutical Holding Company ... |
3.73B |
0.32% |
|
|
|
|
|
36.91 |
-7.19% |
62.50% |
22.73% |
---|
RNA |
Avidity Biosciences, Inc. |
3.71B |
0.32% |
|
|
|
|
|
31.12 |
-4.33% |
67.15% |
32.35% |
---|
CRSP |
CRISPR Therapeutics AG |
4.11B |
0.32% |
|
|
|
|
|
47.87 |
-5.07% |
61.54% |
46.80% |
---|
VCYT |
Veracyte, Inc. |
3.04B |
0.31% |
|
|
|
|
|
39.18 |
-4.56% |
62.23% |
50.66% |
---|
RYTM |
Rhythm Pharmaceuticals, Inc. |
3.45B |
0.31% |
|
|
|
|
|
56.07 |
-2.89% |
54.39% |
34.17% |
---|
SRRK |
Scholar Rock Holding Corporation |
3.53B |
0.30% |
|
|
|
|
|
37.70 |
-3.70% |
62.30% |
11.20% |
---|
NVCR |
NovoCure Limited |
2.39B |
0.30% |
|
|
|
|
|
22.09 |
2.03% |
49.92% |
15.49% |
---|
XENE |
Xenon Pharmaceuticals Inc. |
3.03B |
0.29% |
|
|
|
|
|
39.73 |
0.89% |
55.26% |
36.00% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
3.32B |
0.28% |
|
|
|
|
|
19.95 |
-1.68% |
52.38% |
52.95% |
---|
FOLD |
Amicus Therapeutics, Inc. |
2.75B |
0.28% |
|
|
|
|
|
9.19 |
1.32% |
51.71% |
48.01% |
---|
VCEL |
Vericel Corporation |
2.57B |
0.27% |
|
|
|
|
|
52.00 |
-4.25% |
58.27% |
68.59% |
---|
TWST |
Twist Bioscience Corporation |
2.46B |
0.27% |
|
|
|
|
|
41.31 |
-8.36% |
66.71% |
12.18% |
---|
VRNA |
Verona Pharma plc |
5.56B |
0.26% |
|
|
|
|
|
67.96 |
5.87% |
57.13% |
5.82% |
---|
DNLI |
Denali Therapeutics Inc. |
2.98B |
0.26% |
|
|
|
|
|
20.73 |
-3.98% |
64.25% |
67.19% |
---|
MRUS |
Merus N.V. |
3.24B |
0.25% |
|
|
|
|
|
47.37 |
-0.55% |
47.93% |
28.86% |
---|
SWTX |
SpringWorks Therapeutics, Inc. |
4.33B |
0.24% |
|
|
|
|
|
58.25 |
-2.80% |
110.33% |
57.59% |
---|
ZLAB |
Zai Lab Limited |
3.68B |
0.23% |
|
|
|
|
|
33.78 |
9.00% |
123.26% |
31.64% |
---|
JANX |
Janux Therapeutics, Inc. |
2.08B |
0.23% |
|
|
|
|
|
36.01 |
-3.12% |
81.13% |
31.24% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.31B |
0.22% |
|
|
|
|
|
38.75 |
0.68% |
68.70% |
84.70% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.51B |
0.22% |
|
|
|
|
|
19.90 |
-5.06% |
56.04% |
52.45% |
---|
KYMR |
Kymera Therapeutics, Inc. |
2.38B |
0.22% |
|
|
|
|
|
36.81 |
-1.63% |
67.60% |
98.16% |
---|
XTSLA |
BLK CSH FND TREASURY SL AGENCY |
|
0.21% |
|
|
|
|
|
|
|
|
|
---|
VERA |
Vera Therapeutics, Inc. |
1.81B |
0.21% |
|
|
|
|
|
28.58 |
-3.48% |
65.71% |
41.74% |
---|
RXRX |
Recursion Pharmaceuticals, Inc. |
3.56B |
0.21% |
|
|
|
|
|
9.28 |
-10.34% |
110.40% |
46.29% |
---|
GERN |
Geron Corporation |
1.55B |
0.19% |
|
|
|
|
|
2.5700 |
-2.28% |
92.88% |
21.18% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
1.91B |
0.19% |
|
|
|
|
|
21.85 |
0.55% |
142.62% |
50.52% |
---|
MESO |
Mesoblast Limited |
2.08B |
0.19% |
|
|
|
|
|
16.37 |
-4.99% |
99.63% |
23.12% |
---|
SMMT |
Summit Therapeutics Inc. |
16.30B |
0.19% |
|
|
|
|
|
22.12 |
-4.08% |
89.17% |
21.99% |
---|
BEAM |
Beam Therapeutics Inc. |
2.52B |
0.19% |
|
|
|
|
|
30.43 |
-8.18% |
63.92% |
88.15% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
2.02B |
0.18% |
|
|
|
|
|
35.22 |
4.36% |
67.83% |
61.09% |
---|
DYN |
Dyne Therapeutics, Inc. |
1.43B |
0.18% |
|
|
|
|
|
14.01 |
0.14% |
230.48% |
48.24% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
1.83B |
0.18% |
|
|
|
|
|
47.84 |
-1.81% |
72.63% |
39.34% |
---|
IOVA |
Iovance Biotherapeutics, Inc. |
1.76B |
0.18% |
|
|
|
|
|
5.78 |
3.03% |
116.50% |
80.65% |
---|
MNKD |
MannKind Corporation |
1.59B |
0.18% |
|
|
|
|
|
5.76 |
1.77% |
97.36% |
67.13% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
2.56B |
0.17% |
|
|
|
|
|
27.07 |
-0.11% |
89.13% |
32.58% |
---|
TEM |
TEMPUS AI INC CLASS A |
|
0.17% |
|
|
|
|
|
|
|
|
|
---|
DVAX |
Dynavax Technologies Corporation |
1.75B |
0.17% |
|
|
|
|
|
13.33 |
0.00% |
247.79% |
42.08% |
---|
AKRO |
Akero Therapeutics, Inc. |
3.89B |
0.17% |
|
|
|
|
|
51.84 |
2.49% |
73.43% |
9.65% |
---|
FTRE |
Fortrea Holdings Inc. |
1.33B |
0.17% |
|
|
|
|
|
14.88 |
-4.68% |
63.01% |
73.68% |
---|
APGE |
Apogee Therapeutics, Inc. |
2.02B |
0.17% |
|
|
|
|
|
34.55 |
1.77% |
66.75% |
58.62% |
---|
MIRM |
Mirum Pharmaceuticals, Inc. |
2.52B |
0.16% |
|
|
|
|
|
52.45 |
-1.34% |
49.91% |
47.78% |
---|
XNCR |
Xencor, Inc. |
1.10B |
0.16% |
|
|
|
|
|
15.74 |
-0.32% |
81.40% |
45.37% |
---|
GRFS |
Grifols, S.A. |
6.11B |
0.15% |
|
|
|
|
|
7.45 |
-1.06% |
66.71% |
13.20% |
---|
IMVT |
Immunovant, Inc. |
3.61B |
0.15% |
|
|
|
|
|
21.27 |
4.01% |
77.80% |
92.15% |
---|
TVTX |
Travere Therapeutics, Inc. |
1.91B |
0.15% |
|
|
|
|
|
21.98 |
-6.79% |
77.53% |
13.95% |
---|
WVE |
Wave Life Sciences Ltd. |
1.70B |
0.15% |
|
|
|
|
|
11.13 |
-1.77% |
317.00% |
11.31% |
---|
ARQT |
Arcutis Biotherapeutics, Inc. |
1.52B |
0.15% |
|
|
|
|
|
13.02 |
-2.98% |
80.40% |
53.95% |
---|
TXG |
10x Genomics, Inc. |
1.33B |
0.15% |
|
|
|
|
|
10.90 |
-5.71% |
81.27% |
47.99% |
---|
ALVO |
Alvotech |
3.70B |
0.14% |
|
|
|
|
|
12.28 |
4.96% |
N/A |
N/A |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
1.91B |
0.14% |
|
|
|
|
|
9.21 |
-1.92% |
50.70% |
31.73% |
---|